ArticleERJ open research2026
Reduced cough severity and improved confidence in self-management following completion of a Virtual Physiotherapy Group Intervention for Chronic Cough: ViP-Cough.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prolonged waiting times significantly limited access to our respiratory physiotherapy service for cough control therapy. In response, we developed a virtual physiotherapy group intervention for individuals with chronic cough (ViP-Cough) to improve accessibility. This article describes the uptake and potential benefits of this novel approach. Methods: A service evaluation was carried out utilising a retrospective observational cohort study design involving patients with chronic cough referred to a single-centre respiratory physiotherapy service. All referrals were assessed by a specialist physiotherapist and offered access to ViP-Cough, a single-session virtual group intervention comprising: 1) education and lifestyle advice; 2) cough control strategies; and 3) breathing pattern retraining and vocal hygiene. Patients completed outcome measures at baseline and 4 weeks post-intervention, including numerical rating scales (NRS) for cough severity, frequency and impact on daily activities (0-10; higher scores indicating worse outcomes), and confidence in self-management (0-10; higher scores indicating better outcomes). Descriptive statistics and paired samples t-tests were used for analysis. Results: Of the 194 patients referred (median age 61 years; 79% female), 70% reported cough duration >5 years. Of those screened, 155 (80%) opted in; 116 attended, and 106 completed all assessments. Significant improvements were observed in cough severity (mean difference (95% CI) -1.26 (-0.82- -1.70), p<0.001), frequency (-1.19 (-0.79- -1.60), p<0.001), impact on daily life (-1.16 (-0.23- -1.61), p<0.001) and confidence in self-management (+2.16 (1.64-2.68), p<0.001). Conclusion: ViP-Cough is a promising, scalable and low-cost approach to delivering nonpharmacological cough therapy. These preliminary findings support further evaluation in a randomised controlled trial.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.